Tango Therapeutics Inc (TNGX) — Capital Reinvestment Ratio
Latest as of September 2020:
0.00x
Tango Therapeutics Inc (TNGX) has a Capital Reinvestment Ratio of 0.00x as of September 2020, meaning it reinvests 0% of its operating cash flow ($111.26 Million) in capital expenditures ($132.00K). See TNGX cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$111.26 Million
USD
Capital Expenditures
$132.00K
USD
Data as of
Sep 2020
Most recent filing
Tango Therapeutics Inc Capital Reinvestment Ratio (2020–2020)
This chart tracks Tango Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Tango Therapeutics Inc (2020–2020)
Year-by-year Capital Reinvestment Ratio for Tango Therapeutics Inc from 2020 to 2020. For live market cap and broader valuation context, see Tango Therapeutics Inc stock valuation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.02x | $70.07 Million | $1.11 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow